Tuberculosis Infection in Children

2018 Dodd, 2014, Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study, Lancet Glob Health, 2, e453, 10.1016/S2214-109X(14)70245-1 Haddad, 2018, Simple estimates for local prevalence of latent tuberculosis infection, United States, 2011-2015, Emerg Infect Dis, 24, 1930, 10.3201/eid2410.180716 Miramontes, 2015, Tuberculosis infection in the United States: prevalence estimates from the National Health and Nutrition Examination Survey, 2011-2012, PLos One, 10, 10.1371/journal.pone.0140881 Golub, 2001, Transmission of Mycobacterium tuberculosis through casual contact with an infectious case, Arch Intern Med, 161, 2254, 10.1001/archinte.161.18.2254 Murphy, 2016, Occupational tuberculosis despite minimal nosocomial contact in a health care worker undergoing treatment with a tumor necrosis factor inhibitor, Ann Am Thorac Soc, 13, 2275, 10.1513/AnnalsATS.201608-582LE Marais, 2004, The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era, Int J Tuberc Lung Dis, 8, 392 American Academy of Pediatrics. Report of the Committee on Infectious Diseases. Red Book: Tuberculosis. Online: American Academy of Pediatrics, 2018. https://redbook.solutions.aap.org/. Accessed April 15, 2020. Bibbins-Domingo, 2016, Screening for latent tuberculosis infection in adults: US Preventive Services Task Force recommendation statement, JAMA, 316, 962, 10.1001/jama.2016.11046 American Academy of Pediatrics. Tuberculosis. Bright Futures, 2015. https://brightfutures.aap.org/Bright%20Futures%20Documents/Screening.pdf. Accessed April 15, 2020. 2018 2005, Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations From the National Tuberculosis Controllers Association and CDC, Morb Mortal Wkly Rep, 54, 1 Machingaidze, 2011, The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis, Pediatr Infect Dis J, 30, 694, 10.1097/INF.0b013e318214b915 Lewinsohn, 2017, Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children, Clin Infect Dis, 64, 111, 10.1093/cid/ciw778 Grant, 2012, Procedures for collection of induced sputum specimens from children, Clin Infect Dis, 54, S140, 10.1093/cid/cir1069 2018 Zenner, 2017, Treatment of latent tuberculosis infection: an updated network meta-analysis, Ann Intern Med, 167, 248, 10.7326/M17-0609 Sterling, 2020, Guidelines for the treatment of latent tuberculosis infection: recommendations from the National Tuberculosis Controllers Association and CDC, 2020, MMWR Recomm Rep, 69, 1, 10.15585/mmwr.rr6901a1 Cruz, 2018, Completion rate and safety of tuberculosis infection treatment with shorter regimens, Pediatrics, 141, 10.1542/peds.2017-2838 Spyridis, 2007, The effectiveness of a 9-month regimen of isoniazid alone versus 3-and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study, Clin Infect Dis, 45, 715, 10.1086/520983 Cruz, 2013, Treatment of latent tuberculosis infection in children, J Pediatric Infect Dis Soc, 2, 248, 10.1093/jpids/pit030 Chang, 2014, Hepatotoxicity in children receiving isoniazid therapy for latent tuberculosis infection, J Pediatric Infect Dis Soc, 3, 221, 10.1093/jpids/pit089 Villarino, 2015, Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid, JAMA Pediatr, 169, 247, 10.1001/jamapediatrics.2014.3158 Njie, 2018, Isoniazid-rifapentine for latent tuberculosis infection: a systematic review and meta-analysis, Am J Prev Med, 55, 244, 10.1016/j.amepre.2018.04.030 Borisov, 2018, Update of recommendations for use of once-weekly isoniazid-rifapentine regimen to treat latent Mycobacterium tuberculosis infection, MMWR Morb Mortal Wkly Rep, 67, 723, 10.15585/mmwr.mm6725a5 Diallo, 2018, Safety and side effects of rifampin versus isoniazid in children, N Engl J Med, 379, 454, 10.1056/NEJMoa1714284 Gaensbauer, 2018, Better completion of pediatric latent tuberculosis treatment using 4 months of rifampin in a US-based tuberculosis clinic, Pediatr Infect Dis J, 37, 224, 10.1097/INF.0000000000001721 Ziakas, 2009, 4 months of rifampin compared with 9 months of isoniazid for the management of latent tuberculosis infection: a meta-analysis and cost-effectiveness study that focuses on compliance and liver toxicity, Clin Infect Dis, 49, 1883, 10.1086/647944 Menzies, 2018, Four months of rifampin or nine months of isoniazid for latent tuberculosis in adults, N Engl J Med, 379, 440, 10.1056/NEJMoa1714283 Ena, 2005, Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis, Clin Infect Dis, 40, 670, 10.1086/427802 Comstock, 1979, Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies, Am Rev Respir Dis, 119, 827 Hirsch-Moverman, 2015, Latent tuberculous infection in the United States and Canada: who completes treatment and why?, Int J Tuberc Lung Dis, 19, 31, 10.5588/ijtld.14.0373 Finch, 2002, Rifampin and rifabutin drug interactions: an update, Arch Intern Med, 162, 985, 10.1001/archinte.162.9.985 van Toorn, 2014, Short intensified treatment in children with drug-susceptible tuberculous meningitis, Pediatr Infect Dis J, 33, 248, 10.1097/INF.0000000000000065 2010, Severe isoniazid-associated liver injuries among persons being treated for latent tuberculosis infection-United States, 2004-2008, MMWR Morb Mortal Wkly Rep, 59, 224 Donald, 2011, Antituberculosis drug-induced hepatotoxicity in children, Pediatr Rep, 3, e16, 10.4081/pr.2011.e16